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1. Introduction 
Considerable interest has recently been shown in the 
preparation of immobilized 'general ligands', i.e. sub- 
stances uch as NAD, NADP, ATP and AMP which 
act as ligands or cofactors for groups of enzymes. This 
interest derives both from the need for such immobi- 
lized derivatives in enzyme reactors [ 1-3] and from 
the potential usefulness of such derivatives in affinity 
chromatography [4-12]. The usefulness of immobi- 
lized ligands in studies of enzyme binding mechanisms 
has also been demonstrated [10-13]. A common fea- 
ture of the majority of 'general ligands' is the pre- 
sence of an adenine residue. The 6 position of this re- 
sidue (cf. fig. 1) would appear to be a desirable immo- 
bilization point since available specificity data suggest 
that the amino group in this position may often be 
eliminated or substituted without any drastic deter- 
ioration in the binding properties or effectiveness of 
the cofactors [5, 7, 10, 14]. 
Unfortunately this 6-amino group is unusually 
inert and recent studies have shown that some pre- 
vious attempts at immobilization of NAD + through 
this group, by carbodiimide-promoted attachment to
NH2 SH 
N N N~. 
R R 
Fig. 1. Adenine derivatNes (right) and their 6-mercaptopu- 
rine analogues (left). 
*To whom correspondence should be addressed. 
carboxylated polymers, resulted instead in attach- 
ment largely through the ribosyl hydroxyl groups 
[10]. Attachment of AMP through the 6-amino 
group has indeed been achieved, but only by indi- 
rect means, involvinR relatively complex synthetic 
chemical procedures and relatively extreme condi- 
tions [7]. The difficulties of such approaches seem 
likely to be magnified in the case of more complex 
and unstable ligands such as NAD +. A recently des- 
cribed method making use of succinylated derivati- 
ves of NAD ÷ shows some promise [3], although the 
specificity of the linkage procedure has not been 
established. 
The present communication describes simple pro- 
cedures for the preparation of effective 6-immobili- 
zed analogues of adenine-containing compounds. 
Attachment through the 6 position is achieved by 
using readily available, or readily preparaed, analo- 
gues in which the 6-amino group is replaced by a 
6-mercapto group (fig. 1). The mercapto group con- 
denses pecifically and spontanaeously under mild 
conditions with bromoacetylated matrix-spacer-arm 
assemblies. 
2. Experimental 
2.1.  Mater ia ls  
Sepharose 4B was obtained from Pharmacia, Upp- 
sala. NMN, 6-mercaptopurine riboside-5'-phosphate, 
6-mercaptopurine riboside and 6-methylmercapto- 
purine riboside were supplied by Sigma Chemical Co., 
London. Dicyclohexylcarbodiimide wasobtained 
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Fig. 2. Structures and preparative routes of the 6-immobilized analogues. For details of procedures 1 and 2, see Experimental 
section. 
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from BDH Chemicals Ltd., Poole. The preparation and 
purification of 6-mercaptopurine riboside-5'-triphos- 
phate and nicotinamide-6-mercaptopurine dinucleo- 
tide are as described by Murphy et al. [15] and Todd 
et al. [16] respectively. 
The enzymes were all supplied by Sigma Chemical 
Co., London. Lactate dehydrogenase was assayed fol- 
lowing the method of Fritz et al. [17] but using 0.02 M 
phosphate buffer, pH 7.4, instead of Tris. Adeno- 
sine deaminase was assayed by the method of Kalckar 
[18]. 
2.2. Preparation of the immobilized ligands 
The matrix-spacer-arm assembly terminating in a 
bromoacetyl group (I in fig. 2) was prepared from 
Sepharose 4B following procedures described by Cua- 
trecasas [19]. 
The synthetic procedures involved in the linkage 
and build-up of the ligands, as illustrated in fig. 2, 
are as follows: 
Procedure 1
The bromoacetylated assembly (I, fig. 2, or any 
similar bromoacetylated analogue) iswashed with 
0.1 M NaHCO3, pH 9.0, and the moist, packed gel 
is mixed with an equal volume of the same buffer 
containing the 6-mercaptopurine analogue at a con- 
centration of about 15/amoles per ml. The mixture 
is incubated at room temperature (15°-20°C) for 
five days with occasional stirring and the gel is then 
washed on a sintered-glass funnel with about 200 vol 
of 0.2 M NaCL. Any residual unreacted bromoacetyl 
groups are blocked by further treatment of the gel 
with an equal volume of 0.2 M 2-mercaptoethanol i  
0.01 M NaHCO3, pH 9.0, for 2 hrat 30°C. The gel 
is finally washed with 0.2 M NaC1 (approx. 200 vol) 
and with distilled water (10 vol). 
Procedure 2
The immobilized AMP analogue (derivative III, fig. 
2) is washed on a sintered-glass funnel with 80% aque- 
ous pyridine (v/v) and mixed with an equal volume of 
80% aqueous pyridine (v/v) containing NMN (free 
acid) at a concentration f 10 #moles per ml. 1he mix- 
ture is cooled to 0°-4°C, 93 mg (450/amoles of dicy- 
clohexylcarbodiimide perml of gel is added and dis- 
solved, and the mixture is incubated at 0°-4°C for 8 
days with occasional mixing (dicyclohexyl urea be- 
gins to precipitate out after 3 to 4 days). The gel is 
then washed briefly on a sintered-glass funnel with 
about 12 vol of methanol followed by about 3 vol of 
80% aqueous pyridine. The reaction procedure is re- 
peated, using the same quantities of NMN and dicy- 
clohexylcarbodiimide, butextending the incubation 
time to 16 days at 0°-4°C (the formation of dicy- 
clohexyl urea is slower during this second incubation). 
The gel is washed as before and the reaction procedure 
is repeated once more but prolonging the incubation 
period to 30 days. (This final prolonged incubation 
is optional). The gel is finally washed with methanol 
(about 60 vol) followed by 0.02 M NaC1 (about 100 
vol) and distilled water (10 vol). 
2.3. Spectral monitoring and chromatographic proce- 
dures 
Absorbance spectra of the immobilized nucleoti- 
des were recorded using suspensions of the gels in 
distilled water and a Unicam S.P. 1800 spectrophoto- 
meter. The sample and reference cells were mounted 
near the photodetector to minimize light scattering. 
The blank sample in the reference compartment con- 
sisted of a suspension of the matrix-spacer-arm assem- 
bly (I, fig. 2) without any attached ligand. The con- 
tents of the cells were mixed by inversion immediate- 
ly prior to recording the spectra. 
The Sepharose-linked NAD + analogue was chemi- 
caUy reduced by addition of 250 nag of sodium dithi- 
onite to I rnl of nucleotide gel suspended in 20 ml of 
1.3% NaHCO 3. Nitrogen (99.9%, oxygen-free) was 
bubbled through the suspension and the mixture was 
sealed and incubated at 15°C for 2 hr with continuous 
mixing. The gel was then washed on a sintered-glass 
funnel with 0.2 M NaC1 (100 vol) and distilled water 
(10 vol). 
Enzymic reduction of the Sepharose-linked NAD .+ 
analogue was monitored as follows: the moist gel 
(0.3 ml) was washed with 0.03 M sodium pyrophos- 
phate, pH 8.8, containing 0.5 M KC1 and then incu- 
bated at 30°C in a spectrophotometric cuvette con- 
taining 2.4 ml of the same buffer, 0.2 ml of ethanol 
and 5 units of yeast alcohol de_hydrogenase. The re- 
ference ceil contained the same ingredients minus the 
alcohol dehydrogenase. The contents of the cells were 
kept continually mixed by inversion of the tightly 
capped cells. 
Chromatography was carried out at 15°C, using 
miniature columns (7 mm internal diameter; 3 ml-  
4 ml bed volume) and a hydrostatic head of pressure 
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Fig. 3. Affinity chromatography of adenosine deaminase on 
the 6-immobilized adenosine analogue (derivative II) and of 
lactate dehydrogenase onthe 6-immobilized AMP analogue 
(derivative III). The irrigant for both affinity columns was 
0.1 M KCI in 0.1 M potassium phosphate buffer, pH 7.0, 
with the addition of the appropriate counter ligand to the 
litigant indicated by the horizontal arrows. Effluent volume 
was measured from the time of application of the enzyme 
samples. The breakthrough position is marked by the elution 
peak of a trace of glucose, applied with each enzyme sample 
and monitored in the effluent as previously described [ 13 ]. 
For further details ee Experimental section. (MMPR: methyl- 
mercaptopurine riboside; (o-o-o) adenosine deaminase; 
(e-e-e)  lactate dehydrogenase; ( -  - -) glucose. 
adjusted to give a flow rate of one column volume per 
10 min. Enzyme samples of 0.4 ml were applied and 
the effluent was collected as 0.4 ml fractions using a 
Gilson microfractionator. The effluent volume is ex- 
pressed in terms of column volume units (fig. 3), cali- 
bration being carried out as previously described [13]. 
3. Results and discussion 
Procedure 1 (fig. 2) depends on the spontaneous 
condensation of  the thiol group of the mercaptopu- 
fine residue with the reactive bromoacetyl group, HBr 
being eliminated. This procedure is both simple and 
specific and it has the advantage of involving only 
mild conditions. The resulting immobilized 6-mer- 
captopurine derivatives have an absorbance spectrum 
(~max290 nm) very similar to those of S-substituted 
6-mercaptopurine d rivatives generally, and differing 
from those of  6-mercaptopurine d rivatives in which 
the mercapto group remains unsubstituted. For ex- 
ample under the same conditions 6-methylmercapto- 
purine riboside also has its absorption maximum at 
290 nm while 6-mercaptopurine riboside and its phos- 
phorylated erivatives have the absorbance maximum 
at 322 nm [20]. The spectral difference isdue to tauto- 
merization of  the free mercapto group which is blocked 
in the S-substituted derivatives. This is a clear indica- 
tion that the immobilization linkage is through the 
6-mercapto group as expected. 
The chemistry of procedure 2 is not as clear-cut or 
Precise as that of procedure 1. It is based on the syn- 
thetic method used originally by Todd et al. [16] for 
the synthesis of NAD + by carbodiimide-promoted 
condensation of AMP and NMN in free solution. 
(This same method is also used for the synthesis of 
the 6-mercaptopurine analogue of NAD in free solution 
[ 15 ]. Self condensation of AMP and of NMN are 
side-reactions complicating the free-solution reaction 
and necessitating separation of the NAD + product 
from the side products. However, such complications 
were not expected to be troublesome in the conden- 
sation of  NMN with the immobilized AMP analogue 
(fig. 2), since the immobilized state of the AMP ana- 
logue seems to preclude self-condensation, while the 
product of self-condensation f NMN is simply re- 
moved in the wash. 
The immobilized analogue resulting from proce- 
dure 2 developed a second absorbance peak at 340-  
342 nm upon reduction with sodium dithionite, con- 
firming that NMN had been incorporated. The inten- 
sity of  this absorbance was consistent with 1 : t in- 
corporation of NMN relative to the immobilized 6- 
mercaptopurine analogue. This initially suggested 
quantitative and specific formation of the immobi. 
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lized NAD + analogue (derivative V, fig. 2) by proce- 
dure 2. However, by the same spectrophotometric 
criterion only about 20% reduction was achievable 
enzymicaUy when this immobilized analogue was in- 
cubated in the presence of alcohol dehydrogenase and 
ethanol. Under the same conditions alcohol dehydro- 
genase fails to reduce NMN to a detectable extent, so 
that it can be assumed that at least 20% of the NMN 
incorporated by procedure 2 is 'correctly' linked, to 
the AMP analogue to form an enzymically effective 
NAD + analogue. The reason for the ineffectiveness 
of the remaining 80% is unclear. It may reflect a lack 
of specificity in procedure 2 resulting in a high pro- 
portion of 'incorrectly' linked ligand molecules, or 
it may reflect inhomogeneity in the agarose matrix 
with dense regions inaccessible to the enzyme. 
The proportion of 'effective' NAD + analogue re- 
sidues in derivative V is sufficient o provide an effec- 
tive affinity gel, as mentioned below. Direct linkage 
of the complete, pre-assembled mercaptopurine ana- 
logue of NAD + to the bromoacetylated gel(indicated 
as an alternative preparative route in fig. 2) clearly 
has the advantage of more reliably yielding a more 
homogeneous population of effective immobilized 
ligand residues. However, the cost and trouble of the 
preassembly steps have thus far made the easier and 
less expensive modular solid-phase assembly approach 
a much more attractive proposition, although the pro- 
duct is admittedly less well-defined chemically. 
Efforts to apply a solid-phase modular approach, 
similar to procedure 2, in the synthesis of the ATP 
analogue (derivative IV, fig. 2) by carbodiimide-pro- 
moted attachment of a pyrophosphate group to deri- 
vative III were much less successful. In this case the 
free-solution synthesis of the ATP analogue is relati- 
vely simple and free of complications so that the pre- 
assembly approach as indicated in fig. 2 seems prefer- 
able in this case. 
The immobilized adenosine analogue (derivative 
II, fig. 2) was an effective affinity gel for adenosine 
deaminase, although the affinity was relatively weak, 
as indicated by the slow leakage of the enzyme from 
the columns (fig. 3). The enzyme could be specifi- ~ 
cally and cleanly eluted from the column by addition 
of 6-methylmercaptopurine riboside to the irrigant as 
a counter ligand (fig. 3), confirming the biospecificity 
of the adsorption. This was further indicated by the 
lack of aff'mity of the corresponding AMP-analogue 
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gel (derivative III, fig. 2) for adenosine deaminase 
(fig. 3), in agreement with the known specificity of 
this enzyme. 
By contrast, his 'AMP' gel adsorbed lactate dehydro- 
genase biospecifically, the specificity of binding being 
shown by the specific elution of the enzyme from 
this gel by addition of NADH as a counter ligand to 
the irrigant (fig. 3). (AMP represents half the NAD + 
molecule and is an inhibitor of lactate dehydrogenase 
competitive with respect to NAD + and NADH). Deri- 
vative III showed similar biospecific affinity for some 
other AMP-binding enzymes, uch as liver alcohol de- 
hydrogenase, but it promoted only marginal adsorp- 
tion of others, such as malate dehydrogenase, and it 
showed no detectable affinity at all for adenylate ki- 
nase (myokinase from rabbit muscle). Some other 
AMP-specific enzymes, uch as AMP deaminase from 
rabbit muscle, were very strongly adsorbed in an 
essentially irreversible fashion, seemingly by non- 
biospecific interactions with the hydrocarbon spacer- 
arm. Such non-biospecific adsoption completely eclip- 
sed any biospecific affinity for the ligand (T. Griffin 
and P. O'Carra, unpublished results). 
Thus the general effectiveness envisaged in the ori- 
ginal concept of general-ligand affinity chromato- 
graphy [4, 5] is considerably attenuated in the case 
of this immobilized AMP analogue. The advantages 
as well as the disadvantages of such attenuation have 
been discussed elsewhere [ 10,21 ] in relation to some- 
what similar behaviour which we have noted in the 
case of certain other immobilized 'general-ligands' - 
in particular certain immobilized NAD + derivatives 
attached via an azo-linkage, apparently through the 
8 position of the adenine residue [10]. 
By contrast with the patchy effectiveness of these 
azo-linked NAD + derivatives the 6-1inked NAD + ana- 
logue described here (derivative V, fig. 2), was a very 
~ffective affinity adsorbent for all the NAD ÷ linked 
dehydrogenases o far tested. These include lactate, 
malate, alcohol and glyceraldehyde-3-phosphate de- 
hydrogenase. Thus derivative V comes much closer 
to the general-ligand ideal, but it remains to be esta- 
blished whether this is an unqualified advantage (cf. 
refs. [10, 21]). 
A comprehensive study of the affinity chromato- 
graphic applications of these immobilized erivatives 
and of the ATP analogue (derivative IV), both in en- 
zyme purification and in mechanistic studies, is in 
progress and will be published elsewhere. 
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